middl
east
respiratori
syndrom
coronaviru
merscov
first
isol
zaki
cowork
june
saudi
male
age
year
die
sever
pneumonia
renal
failur
current
viru
affect
individu
countri
across
globe
claim
live
thu
pose
public
health
challeng
arabian
peninsula
elsewher
figur
merscov
outbreak
began
decad
epidem
sever
acut
respiratori
syndrom
sar
caus
global
scare
affect
peopl
across
world
kill
one
tenth
howev
unlik
sar
disappear
within
year
merscov
epidem
continu
tabl
sinc
discoveri
number
excel
review
publish
describ
import
aspect
merscov
middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
lower
respiratori
tract
infect
human
consid
pandem
threat
gulf
region
sinc
discoveri
merscov
reach
countri
affect
peopl
includ
dozen
children
claim
live
compar
sar
sever
acut
respiratori
syndrom
merscov
appear
kill
peopl
versu
quickli
especi
sever
preexist
medic
condit
merscov
case
report
thu
far
histori
resid
travel
middl
east
current
epidemiolog
characteris
slow
sustain
transmiss
occasion
spark
dromedari
camel
intermedi
host
merscov
transmiss
cycl
fulli
understood
current
review
briefli
summaris
latest
inform
epidemiolog
clinic
featur
diagnosi
treatment
prevent
merscov
especi
highlight
knowledg
gap
transmiss
dynam
diagnosi
prevent
strategi
elsevi
ltd
right
reserv
sum
current
research
gap
light
spectrum
burn
question
rang
clinic
present
molecular
virolog
review
summaris
latest
find
field
merscov
especi
molecular
virolog
epidemiolog
clinic
featur
diagnosi
infect
control
manag
plan
highlight
knowledg
gap
transmiss
mode
attempt
explain
unansw
question
rais
investig
literatur
search
perform
pubm
prome
mail
googl
googl
scholar
articl
publish
septemb
march
follow
vocabulari
term
use
coronaviru
merscov
coronaviru
merscov
merscov
review
merscov
infect
merscov
outbreak
merscov
case
studi
report
merscov
camel
merscov
bat
merscov
transmiss
merscov
pathogenesi
merscov
antibodi
merscov
receptor
merscov
anim
merscov
diagnosi
merscov
treatment
merscov
vaccin
merscov
saudi
merscov
health
care
worker
merscov
positivesens
envelop
singlestrand
rna
viru
belong
genu
betacoronaviru
within
subfamili
coronavirina
known
begin
various
novel
corona
viru
ncov
cov
merscov
becom
first
lineag
betacoronaviru
known
infect
human
sequenc
homolog
merscov
close
relat
bat
coronavirus
lineag
sar
lineag
genet
relat
betacoronavirus
isol
bat
europ
mexico
africa
hong
kong
china
follow
first
isol
viru
propag
african
green
monkey
rhesu
macaqu
kidney
cell
vero
cell
line
respect
subsequ
cell
line
includ
human
deriv
cell
like
hfl
hek
merscov
propag
well
human
bronchial
lung
tissu
cell
line
deriv
camel
goat
function
replic
merscov
speci
includ
dog
cat
mice
hamster
ferret
equid
indic
bind
site
merscov
could
vari
speci
hemida
et
al
describ
full
genom
merscov
dromedari
demonstr
homolog
human
clade
b
merscov
confirm
subsequ
studi
merscov
also
high
sequenc
homolog
coronaviru
carri
pipistrellu
bat
electron
microscopi
reveal
virion
contain
clublik
project
repres
viral
spike
peplom
eman
viral
membran
merscov
gain
entri
target
cell
bind
receptor
bind
domain
rbd
spike
glycoprotein
human
receptor
dipeptidyl
peptidas
wherea
sar
enter
target
cell
via
angiotensin
convert
enzym
commonli
express
human
organ
kidney
merscov
utilis
host
proteas
gain
entri
lung
cell
spike
protein
viral
envelop
activ
proteas
call
furin
mediat
membran
fusion
eventu
support
viru
entri
host
cell
consequ
proteas
inhibitor
eg
camostat
found
block
merscov
entri
cell
merscov
inocul
rhesu
macaqu
caus
transient
lower
respiratori
tract
infect
multifoc
mild
mark
interstiti
pneumonia
viru
replic
occur
mainli
alveolar
pneumocyt
caus
extens
lethal
pneumonia
common
marmoset
vitro
experi
suggest
unlik
sar
merscov
cytopath
effect
kidney
cell
compar
sar
mer
patient
like
develop
acut
renal
failur
detail
pathogenesi
merscov
either
human
anim
avail
dromedari
human
strain
merscov
compar
replic
cell
respiratori
tropism
disrupt
interferon
respons
strain
caus
alveolar
epitheli
damag
apoptosi
variou
part
lung
transgen
mous
model
mer
viral
particl
observ
lung
brain
spleen
intestin
heart
tissu
analysi
necessari
understand
virushost
interact
detail
pathogenesi
merscov
infect
vivo
sinc
first
discoveri
merscov
reach
twenti
countri
march
merscov
case
report
saudi
arabia
n
follow
unit
arab
emir
jordan
qatar
hand
case
report
oman
egypt
franc
germani
tunisia
itali
algeria
iran
netherland
greec
kuwait
lebanon
malaysia
philippin
yemen
austria
turkey
unit
kingdom
unit
state
figur
although
progress
diseas
initi
phase
much
slower
basic
reproduct
number
r
ci
latest
estim
suggest
diseas
actual
higher
variabl
r
rang
depend
geograph
region
tabl
avail
data
suggest
healthcar
exposur
import
risk
factor
merscov
infect
mathemat
model
suggest
nosocomi
transmiss
four
time
higher
commun
transmiss
risk
factor
like
low
humid
high
temperatur
also
import
limit
studi
suggest
season
pattern
spike
march
april
men
age
year
peopl
preexist
medic
condit
health
care
worker
high
risk
group
merscov
infect
median
incub
period
humantohuman
transmiss
approxim
day
rang
day
merscov
caus
symptom
similar
sar
distinct
clinic
cours
high
case
fatal
rate
case
present
symptom
influenzalik
ill
ili
fever
cough
predominantli
dri
malais
myalgia
sore
throat
headach
rhinorrhoea
nausea
vomit
abdomin
pain
diarrhoea
even
renal
failur
occur
occasion
dyspnoea
frequent
complaint
major
patient
develop
pneumonia
ultim
requir
admiss
intens
care
unit
icu
concomit
infect
hypoalbuminemia
identifi
predictor
sever
infect
individu
age
year
extrapulmonari
organ
dysfunct
circulatori
collaps
abnorm
liver
function
hematolog
derang
common
critic
ill
patient
secondtrimest
stillbirth
report
pregnant
woman
merscov
merscov
common
adult
dozen
paediatr
case
includ
fatal
report
date
paediatr
case
asymptomat
found
screen
process
among
close
famili
contact
merscov
patient
commun
hospit
children
underli
medic
condit
higher
risk
merscov
infect
mortal
merscov
higher
men
preexist
medic
condit
median
time
symptom
onset
hospitalis
approxim
day
time
icu
admiss
approxim
day
ventilatori
care
requir
median
day
durat
icu
stay
day
howev
fatal
occur
median
day
follow
symptom
onset
day
mortal
mer
patient
icu
chest
radiograph
merscov
patient
typic
show
bilater
enhanc
hilar
vascular
shadow
promin
left
side
accentu
bronchovascular
mark
multipl
patchi
opac
middl
lower
lung
field
consolid
right
upper
lobe
occur
earli
one
day
onset
ill
ground
glass
opac
consolid
left
lower
lobe
occur
within
day
symptom
onset
bilater
groundglass
opac
consolid
occur
respect
day
onset
ill
sinc
merscov
case
present
symptom
similar
respiratori
viral
infect
case
detect
pure
base
syndrom
diagnosi
challeng
sinc
first
discoveri
viru
comprehens
laboratori
test
develop
serolog
assay
wide
use
detect
merscov
antibodi
dromedari
camel
convent
rapid
biolog
safe
immunofluoresc
assay
detect
merscov
antibodi
publish
igg
igm
antibodi
serum
sampl
could
determin
use
antimerscov
indirect
immunofluoresc
assay
addit
enzymelink
immunosorb
assay
elisa
protein
microarray
technolog
microneutralis
mn
assay
also
develop
high
sensit
specif
detect
merscov
antibodi
seroepidemiolog
studi
assay
like
pseudoparticl
viru
neutralis
test
ppnt
convent
mn
assay
could
use
detect
antibodi
merscov
western
blot
also
use
serolog
diagnosi
merscov
howev
serolog
test
may
lack
valid
cross
react
coronavirus
accord
world
health
organ
expert
field
screen
rtpcr
target
e
gene
conduct
sampl
suspect
mer
patient
posit
sampl
undergo
confirmatori
test
tagert
orf
orf
n
gene
endeavour
made
obtain
lower
respiratori
tract
sampl
bronchoalveolar
lavag
tracheal
aspir
sinc
viral
load
genom
fraction
higher
lower
respiratori
tract
sampl
sequenc
data
use
construct
phylogenet
tree
order
measur
genet
distanc
virus
differ
intermedi
host
date
approv
antivir
therapi
vaccin
avail
merscov
base
vitro
experi
experi
sar
patient
variou
treatment
option
attempt
suggest
omrani
et
al
show
patient
sever
merscov
infect
ribavirin
interferon
therapi
significantli
associ
improv
surviv
day
day
vitro
studi
also
suggest
ribavirin
interferon
combin
therapi
signific
antivir
effect
use
distinct
clone
monoclon
antibodi
domain
involv
bind
merscov
identifi
suggest
clone
humanis
monoclon
antibodi
could
potenti
therapeut
agent
merscov
one
antibodi
neutralis
viru
except
potenc
therefor
potenti
candid
drug
could
even
use
vaccin
design
addit
human
microrna
might
use
antivir
therapi
merscov
infect
case
hospitalis
patient
untest
convalescentphas
plasma
suggest
support
therapi
minimis
sever
infect
candid
vaccin
test
mice
promis
result
subunit
vaccin
base
merscov
spike
protein
rbd
could
use
develop
merscov
vaccin
inhibit
papainlik
proteas
merscov
regul
polyprotein
merscov
genom
rna
could
use
concept
vaccin
design
control
merscov
primarili
reli
casebas
surveil
earli
diagnosi
warrant
infect
suspect
role
respiratori
protect
equip
surgic
mask
respir
discuss
yet
proven
larg
studi
examin
role
facemask
merscov
among
hajj
pilgrim
current
underway
although
person
person
transmiss
limit
travel
middl
east
could
risk
exposur
merscov
rais
awar
merscov
transmiss
import
view
fact
mani
travel
awar
merscov
outbreak
essenti
intensifi
infect
control
measur
health
care
set
particularli
health
educ
awar
healthcar
worker
also
need
follow
stringent
precaut
handl
suspect
merscov
patient
includ
use
eye
protector
person
protect
equip
immunocompromis
individu
preexist
medic
condit
avoid
close
contact
dromedari
camel
particularli
viru
known
circul
area
similarli
raw
camel
milk
meat
urin
avoid
import
current
research
gap
mechan
peopl
acquir
merscov
unclear
mechan
exposur
whether
direct
indirect
difficult
explain
experi
fraught
challeng
serolog
molecular
evid
presenc
viru
establish
domest
dromedari
livestock
viru
also
recov
respiratori
gastrointestin
bodili
secret
sampl
dromedari
camel
fruit
bat
serolog
evid
merscov
anim
worker
rare
merscov
detect
air
sampl
collect
barn
shelter
infect
camel
own
infect
patient
indic
possibl
airborn
transmiss
viru
secondli
direct
transmiss
whether
human
camel
vice
versa
unknown
merscov
identifi
dromedari
camel
qatari
barn
link
two
confirm
human
case
sinc
recov
also
possibl
inocul
merscov
healthi
camel
ultim
produc
upper
respiratori
tract
symptom
could
establish
whether
peopl
farm
infect
camel
vice
versa
third
sourc
respons
thirdli
remain
unclear
third
intermedi
host
play
key
role
transmiss
chain
phylogenet
studi
reveal
close
relationship
merscov
human
coronavirus
bat
exact
viru
confirm
bat
noteworthi
human
coronavirus
emerg
upon
transmiss
bat
anim
speci
although
other
report
short
genom
sequenc
isol
egyptian
tomb
bat
taphoz
perfor
ident
merscov
essen
isol
dearth
inform
establish
associ
bat
viru
fourthli
report
suggest
merscov
transmit
humantohuman
avail
data
show
uncertainti
limit
humantohuman
transmiss
viru
low
level
viru
shed
might
explan
humantohuman
transmiss
limit
unlik
final
evolutionari
background
merscov
still
unclear
merscov
might
circul
camel
saudi
arabia
sinc
least
merscov
antibodi
found
african
camel
suggest
viru
exist
camel
long
time
howev
merscov
camel
may
undergon
mutat
sever
year
ago
allow
viru
infect
human
pauciti
data
describ
transmiss
cycl
merscov
variou
host
welldesign
larg
scale
casecontrol
studi
need
defin
transmiss
chain
merscov
research
safe
effect
antivir
treatment
need
prioritis
condit
high
mortal
rate
threaten
pandem
